Human iPSC-derived ventricular-like cardiomyocytes
Ventricular cardiomyocytes generated with our standardized process are fully functional. Their relatively slow beat rate enables pacing for electrophysiological research. Base on this model, an array of functional assays can be developed and optimized providing relevant predictions of drug-induced responses.
Our team can generate cardiomyocytes from the iPSC that best fits your project or work with off-the-shelf Ncyte Cardiomyocytes Kit to support your projects.
- High purity ventricular-like cardiomyocytes
- Physiologically relevant
- Highly suitable for electrophysiological research
Are you looking to use human iPSC-derived cardiomyocytes for your drug discovery projects?
Ncyte Cardiomyocytes are characterized by flow cytometry to ensure a purity of ≥ 70% cardiac TroponinT (cTnT) positive cells after 3 days in culture following Ncardia’s user guide (See figure A). They typically express Myosin Light Chain 2v (MLC2v), indicating a ventricularlike phenotype (See figure B). Based on RNA-seq data, Ncyte Cardiomyocytes express common sarcomere markers, such as TNNT2, while hiPSC and cardiac progenitor markers are silenced. Expression levels for additional genes are available upon request.
Ncyte Cardiomyocytes exhibit well aligned myofibrils and intact structural sarcomere organization (See figure A). Their action potential shows fast upstroke velocity and a well-defined plateau phase, resembling human ventricular cardiomyocytes (See figure B). These make the Ncyte Cardiomyocytes a physiologically relevant model for the phenotypic study of cardiac diseases. Our expert scientists can develop and execute predictive assays to support your drug discovery research in the cardiac field.
Ncyte Cardiomyocytes present a relatively slow and uniform beating rate, which enables pacing for electrophysiological research (See top figure). Additionally, response to adrenergic stimulation with isoproterenol and ion channel blockers, nifedipine (L-type calcium channel blocker) and dofetilide (hERG channel blocker), is guaranteed for every batch (See figure A, B, C). Our scientific team is experienced in the electrophysiological analysis of Ncyte Cardiomyocytes for safety and efficacy studies and can report the analyzed results to you.
Our work centers on a simple yet powerful premise:
When we combine deep iPSC knowledge, broad assay capabilities and a demonstrated ability to integrate the biology of human diseases into preclinical research, we can help drug developers make critical decisions earlier and with more confidence.
Human iPSC-derived astrocytesCardiac
Human iPSC-derived atrial cardiomyocytesNeural
Human iPSC-derived neurons and astrocytesNeural
Human iPSC-derived cortical neuronsNeural
Human iPSC-derived peripheral neuronsCardiac
Human iPSC-derived vascular endothelial cellsCardiac
Human iPSC-derived vascular smooth muscle cellsCardiac
Human iPSC-derived ventricular cardiomyocytes